Faculty introduction, disclosures
Introductory content and review of advanced RCC ·        Statistics, prognosis ·        Healthcare burden
Treatment considerations for advanced RCC, including guideline-based approaches and clinical trial evidence  ·        Goals of therapy ·        Factors impacting decision-making: favorable vs. intermediate- or poor-risk advanced RCC, eligibility for immunotherapy ·        Present treatment approaches o   Clear cell advanced RCC -  Initial therapy ·        Preferred: immunotherapy and/or tyrosine kinase inhibition ·        Additional options -  Assessment of response -  Next-line therapies, with considerations including: prior therapy and patient suitability/tolerance o   Non-clear cell advanced RCC, including less common types ·        Emerging strategies and therapies ·        Treatment challenges, gaps in care o   Adverse effect identification and management o   Gaps in care ·        Patient case(s)
Summary, conclusions, and best practice recap

By the end of the session the participant will be able to:

• Recall the pathophysiology of advanced RCC such that it informs treatment mechanisms.
• Describe: present and emerging treatment options for advanced RCC; their place or anticipated place in therapy; and risk-benefit profiles.
• Formulate a treatment plan for a patient with advanced RCC.

ACCME Activity #203272118

ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.

As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.

Disclosures of Faculty: Sumanta Kumar Pal, MD, Professor & Vice Chair of Academic Affairs, Department of Medical Oncology & Therapeutic Research, City of Hope National Medical Center, has received financial compensation from Allogene Therapeutics, CRISPR Therapeutics, Eisai, Genentech, Pfizer grant/research support.

Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, President of ScientiaCME, has no relevant financial disclosures.  

Faculty WILL discuss off-label uses of a commercial product. 

All relevant financial relationships have been mitigated. 

ScientiaCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Commercial Support Disclosure: This program is supported by an educational grant from Merck. 

• Read the learning objectives above
• Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
• View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
• Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
• Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

*Required to view Printable PDF Version